SPDR S&P Biotech ETF
451 hedge funds and large institutions have $6.32B invested in SPDR S&P Biotech ETF in 2019 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 139 increasing their positions, 130 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
451
Holders Change
+24
Holders Change %
+5.62%
% of All Funds
9.78%
Holding in Top 10
14
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.3%
New
83
Increased
139
Reduced
130
Closed
52
Calls
$1.14B
Puts
$2.64B
Net Calls
-$1.5B
Net Calls Change
-$627M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$1.08B |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
$545M |
| 3 |
JPMorgan Chase & Co
New York
|
$431M |
| 4 |
Goldman Sachs
New York
|
$761M |
| 5 |
Barclays
London,
United Kingdom
|
$211M |
